Table 2.
CC chemokine receptor expression on CD4+ and CD8+ T cells from distinct subjects*
| Normal† | actSLE† | inaSLE† | ||||
|---|---|---|---|---|---|---|
| CCR(%)‡ | CD4+ | CD8+ | CD4+ | CD8+ | CD4+ | CD8+ |
| CCR3 | 3·2±1·2 | 5·3±1·2 | 3·8±1·8 | 4·7±1·9 | 5·4±2·7 | 5·1±2·2 |
| CCR4 | 23±8 | 25±12 | 47±10 | 45±11 | 17±9 | 23±7 |
| CCR5 | 25±9 | 7·3±5·2 | 27±10 | 6·9±2·9 | 16±5 | 10±3·2 |
| CCR7 | 16±11 | 26±9 | 17±9 | 93±11 | 18±6 | 19±13 |
| CCR9 | 5·6±4·5 | 6·3±4·8 | 43±18 | 33±14 | 33±10 | 20±11 |
*The data in the table were the mean values ± SD from a total of six experiments performed in each group.
†The experiments were conducted in purified CD4+ or CD8+ T cells from normal subjects (Normal), patients with active SLE (actSLE) and inactive SLE (inaSLE).
‡The data shown are percentages of CC chemokine receptor-positive cells.